UC Davis Comprehensive Cancer Center http://www.ucdmc.ucdavis.edu/publish/rss/{$key} UC Davis Comprehensive Cancer Center news UC Davis Comprehensive Cancer Center http://www.ucdmc.ucdavis.edu/global/images/wordmarks/cancer_center.gif http://www.ucdmc.ucdavis.edu/publish/rss/cancercenter UC Davis Comprehensive Cancer Center news Protein may improve liver regeneration http://www.ucdmc.ucdavis.edu/publish/news/cancer/9856/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_9856 SACRAMENTO, Calif. (March 31, 2015) - Researchers at UC Davis have illuminated an important distinction between mice and humans: how human livers heal. The difference centers on a protein called PPARα, which activates liver regeneration. Normally, mouse PPARα is far more active and efficient than the human form, allowing mice to quickly regenerate damaged livers. However, the research shows that protein fibroblast growth factor 21 (FGF21) can boost the regenerative effects of human PPARα. Tue, 31 Mar 2015 00:00:00 PDT http://www.ucdmc.ucdavis.edu/publish/news/cancer/9856 Dorsey Griffith 2015-03-31T00:00:00Z UC Davis scientists describe novel drug mechanism that fights brain cancer http://www.ucdmc.ucdavis.edu/publish/news/cancer/9777/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_9777 SACRAMENTO, Calif. (March 3, 2015) - Researchers at UC Davis have developed and characterized a molecule that interferes with the internal regulation of cancer cells, causing them to self-destruct. This novel mechanism was found to be effective against glioma cells – responsible for a usually fatal type of brain cancer – and could be applicable to other highly aggressive cancers. Tue, 03 Mar 2015 00:00:00 PST http://www.ucdmc.ucdavis.edu/publish/news/cancer/9777 Dorsey Griffith 2015-03-03T00:00:00Z UC Davis designated a Lung Cancer Screening Center http://www.ucdmc.ucdavis.edu/publish/news/cancer/9715/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_9715 SACRAMENTO, Calif. (February 11, 2015) - UC Davis Health System has been endorsed by the American College of Radiology as a designated lung cancer screening center, the only of its kind currently in the greater Sacramento area. Wed, 11 Feb 2015 00:00:00 PST http://www.ucdmc.ucdavis.edu/publish/news/cancer/9715 Dorsey Griffith 2015-02-11T00:00:00Z California breast density law slow to have an impact http://www.ucdmc.ucdavis.edu/publish/news/cancer/9667/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_9667 SACRAMENTO, Calif. (January 28, 2015) - Ten months after California legislators enacted a controversial law mandating that radiologists notify women if they have dense breast tissue, UC Davis researchers have found that half of primary care physicians are still unfamiliar with the law and many don’t feel comfortable answering breast density-related questions from patients. Wed, 28 Jan 2015 00:00:00 PST http://www.ucdmc.ucdavis.edu/publish/news/cancer/9667 Susan Mar 2015-01-28T00:00:00Z Moon Chen's research featured in ASCO's 2015 cancer progress report http://www.ucdmc.ucdavis.edu/publish/news/cancer/9643/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_9643 SACRAMENTO, Calif. (January 21, 2015) - UC Davis professor Moon Chen’s research on the under-representation of minorities in clinical trials appears in the American Society in Clinical Oncology (ASCO)’s annual cancer progress report released Tuesday. Wed, 21 Jan 2015 00:00:00 PST http://www.ucdmc.ucdavis.edu/publish/news/cancer/9643 Susan Mar 2015-01-21T00:00:00Z Too much, too little, just right http://www.ucdmc.ucdavis.edu/publish/news/cancer/9553/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_9553 SACRAMENTO, Calif. (December 15, 2014) - Scientists have long known the p53 protein suppresses tumors. However, a recent animal study by UC Davis researchers has uncovered a complicated relationship between p53 and another protein, Rbm38, highlighting how the body calibrates protein levels. Too much Rbm38 reduces p53 levels, increasing the risk of cancer. Too little Rbm38 allows p53 overexpression, causing premature aging. The study was published in the journal PNAS on Dec. 15.  Mon, 15 Dec 2014 00:00:00 PST http://www.ucdmc.ucdavis.edu/publish/news/cancer/9553 Susan Mar 2014-12-15T00:00:00Z 'Tis the season to indulge in walnuts http://www.ucdmc.ucdavis.edu/publish/news/cancer/9471/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_9471 SACRAMENTO, Calif. (November 13, 2014) - Researchers at UC Davis and other institutions have found that diets rich in whole walnuts or walnut oil slowed prostate cancer growth in mice. In addition, both walnuts and walnut oil reduced cholesterol and increased insulin sensitivity. Thu, 13 Nov 2014 00:00:00 PST http://www.ucdmc.ucdavis.edu/publish/news/cancer/9471 Susan Mar 2014-11-13T00:00:00Z UC Davis "out-of-the-box thinker" wins cancer research award http://www.ucdmc.ucdavis.edu/publish/news/cancer/9464/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_9464 SACRAMENTO, Calif. (November 12, 2014) - UC Davis medical oncologist Jonathan Riess is the recipient of a 2014 Young Innovators Team Award for Lung Cancer Research, and will share a $500,000 for translational lung cancer research with two other physician-scientists. Wed, 12 Nov 2014 00:00:00 PST http://www.ucdmc.ucdavis.edu/publish/news/cancer/9464 Susan Mar 2014-11-12T00:00:00Z Lung cancer screening for Medicare patients coming soon to UC Davis http://www.ucdmc.ucdavis.edu/publish/news/cancer/9459/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_9459 SACRAMENTO, Calif. (November 10, 2014) - UC Davis Medical Center is preparing to screen seniors on Medicare who meet the criteria for lung cancer screening using low-dose computed tomography (CT). Mon, 10 Nov 2014 00:00:00 PST http://www.ucdmc.ucdavis.edu/publish/news/cancer/9459 Susan Mar 2014-11-10T00:00:00Z Immunotherapy for cancer toxic with obesity http://www.ucdmc.ucdavis.edu/publish/news/cancer/9429/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_9429 SACRAMENTO, Calif. (November 3, 2014) - Immunotherapy that can be effective against tumors in young, thin mice can be lethal to obese ones, a new study by UC Davis researchers has found. [en español] Mon, 03 Nov 2014 00:00:00 PST http://www.ucdmc.ucdavis.edu/publish/news/cancer/9429 Susan Mar 2014-11-03T00:00:00Z UC Davis researchers examine risks, benefits of chemotherapy for early-stage breast cancer http://www.ucdmc.ucdavis.edu/publish/news/cancer/9413/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_9413 SACRAMENTO, Calif. (October 31, 2014) - Treatment for early stage breast cancer is highly effective, and for many women considering treatment choices, chemotherapy may add little to an already high long-term survival rate. Joy Melnikow, professor in the Department of Family and Community Medicine and Director of the Center for Healthcare Policy and Research at UC Davis, is working to define the potential long-term harms of chemotherapy for these patients, so they can be weighed against the potential benefits. Fri, 31 Oct 2014 00:00:00 PDT http://www.ucdmc.ucdavis.edu/publish/news/cancer/9413 Dorsey Griffith 2014-10-31T00:00:00Z Study on Western diet and role in GI cancer funded http://www.ucdmc.ucdavis.edu/publish/news/cancer/9408/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_9408 SACRAMENTO, Calif. (October 28, 2014) - The National Cancer Institute (NCI) has awarded a $2.7 million grant to UC Davis researchers to investigate how the so-called Western diet, which is high in fat and sugar, increases the risk of developing liver and gastrointestinal (GI) cancers. In addition, the researchers will study whether bifidobacteria, a common family of bacteria in the human gut, can be enriched to prevent cancer. Tue, 28 Oct 2014 00:00:00 PDT http://www.ucdmc.ucdavis.edu/publish/news/cancer/9408 Dorsey Griffith 2014-10-28T00:00:00Z Anti-cancer drug found effective against common stem cell transplant complication http://www.ucdmc.ucdavis.edu/publish/news/cancer/9394/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_9394 SACRAMENTO, Calif. (October 24, 2014) - Researchers at UC Davis have found that the drug bortezomib effectively treats chronic graft-versus-host disease (GVHD), a common and debilitating side effect from allogeneic hematopoietic stem cell transplants. Fri, 24 Oct 2014 00:00:00 PDT http://www.ucdmc.ucdavis.edu/publish/news/cancer/9394 Susan Mar 2014-10-24T00:00:00Z Distinguished cancer prevention researcher to lead public health sciences at UC Davis http://www.ucdmc.ucdavis.edu/publish/news/cancer/9361/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_9361 SACRAMENTO, Calif. (October 21, 2014) - Brad Pollock, a leading researcher on the incidence and control of childhood and adolescent cancer, has become chair of the Department of Public Health Sciences at the UC Davis School of Medicine. Tue, 21 Oct 2014 00:00:00 PDT http://www.ucdmc.ucdavis.edu/publish/news/cancer/9361 Karen Finney 2014-10-21T00:00:00Z NCI awards UC Davis $1.5 million to innovate robotic surgery for head and neck cancers http://www.ucdmc.ucdavis.edu/publish/news/cancer/9378/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_9378 SACRAMENTO, Calif. (October 21, 2014) - The National Cancer Institute (NCI) has awarded UC Davis principal investigators Laura Marcu and Gregory Farwell $1.5 million to adapt UC Davis-developed biophotonic technology to a robotic surgical device in hopes of dramatically improving the precision of head and neck cancer surgery. Tue, 21 Oct 2014 00:00:00 PDT http://www.ucdmc.ucdavis.edu/publish/news/cancer/9378 Susan Mar 2014-10-21T00:00:00Z Cancer Center wins $1.7 million NCI grant to study novel cancer treatment http://www.ucdmc.ucdavis.edu/publish/news/cancer/9337/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_9337 SACRAMENTO, Calif. (October 10, 2014) - A multidisciplinary team at UC Davis will embark on research to determine whether combining a novel type of immunotherapy with radiation and chemotherapy can make treatment for sarcoma, breast and pancreatic cancers more effective. Fri, 10 Oct 2014 00:00:00 PDT http://www.ucdmc.ucdavis.edu/publish/news/cancer/9337 Susan Mar 2014-10-10T00:00:00Z Cancer center's Brain Innovation Group funded for brain tumor tool http://www.ucdmc.ucdavis.edu/publish/news/cancer/9287/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_9287 SACRAMENTO, Calif. (September 24, 2014) - The UC Davis Comprehensive Cancer Center’s Brain Innovation Group has received a grant from the National Cancer Institute (NCI) to improve brain cancer surgery and treatment using UC Davis-developed biophotonic technology. Wed, 24 Sep 2014 00:00:00 PDT http://www.ucdmc.ucdavis.edu/publish/news/cancer/9287 Susan Mar 2014-09-24T00:00:00Z UC Davis-developed target leukemia treatment shows promise http://www.ucdmc.ucdavis.edu/publish/news/cancer/9243/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_9243 SACRAMENTO, Calif. (September 11, 2014) - Noriko Satake, UC Davis pediatric oncologist and researcher, has demonstrated in laboratory studies that a new, targeted treatment for leukemia is effective. Thu, 11 Sep 2014 00:00:00 PDT http://www.ucdmc.ucdavis.edu/publish/news/cancer/9243 Susan Mar 2014-09-11T00:00:00Z Introducing the multi-tasking nanoparticle http://www.ucdmc.ucdavis.edu/publish/news/cancer/9051/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_9051 SACRAMENTO, Calif. (August 26, 2014) - mKit Lam and colleagues from UC Davis and other institutions have created dynamic nanoparticles (NPs) that could provide an arsenal of applications to diagnose and treat cancer. Built on an easy-to-make polymer, these particles can be used as contrast agents to light up tumors for MRI and PET scans or deliver chemo and other therapies to destroy tumors. In addition, the particles are biocompatible and have shown no toxicity. The study was published online today in Nature Communications. Tue, 26 Aug 2014 00:00:00 PDT http://www.ucdmc.ucdavis.edu/publish/news/cancer/9051 Dorsey Griffith 2014-08-26T00:00:00Z California isn't measuring up in the fight against cancer http://www.ucdmc.ucdavis.edu/publish/news/cancer/9193/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_9193 SACRAMENTO, Calif. (August 21, 2014) - In a media briefing at the UC Davis Comprehensive Cancer Center, the American Cancer Society Cancer Action Network released How Do You Measure Up?, an annual report that scores each state on how they are doing in the fight against cancer. Thu, 21 Aug 2014 00:00:00 PDT http://www.ucdmc.ucdavis.edu/publish/news/cancer/9193 Susan Mar 2014-08-21T00:00:00Z Novel drug action against solid tumors explained http://www.ucdmc.ucdavis.edu/publish/news/cancer/9171/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_9171 SACRAMENTO, Calif. (August 11, 2014) - Researchers at UC Davis, City of Hope, Taipai Medical University and National Health Research Institutes in Taiwan have discovered how a drug that deprives the cells of a key amino acid specifically kills cancer cells. Mon, 11 Aug 2014 00:00:00 PDT http://www.ucdmc.ucdavis.edu/publish/news/cancer/9171 Susan Mar 2014-08-11T00:00:00Z Pan awarded grant to test 'smart' chemotherapy drug for bladder cancer http://www.ucdmc.ucdavis.edu/publish/news/cancer/9168/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_9168 SACRAMENTO, Calif. (August 7, 2014) - UC Davis Comprehensive Cancer Center oncologist Chong-Xian Pan has received a $650,000 grant from the VA Northern California Health Care System to conduct the first clinical trial of a novel chemotherapy-delivery drug he developed for bladder cancer patients. Thu, 07 Aug 2014 00:00:00 PDT http://www.ucdmc.ucdavis.edu/publish/news/cancer/9168 Susan Mar 2014-08-07T00:00:00Z UC Davis researcher receives NSFC grant to find new gastric cancer genes http://www.ucdmc.ucdavis.edu/publish/news/cancer/9120/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_9120 SACRAMENTO, Calif. (July 18, 2014) - No Stomach for Cancer Foundation (NSFC) has awarded cancer geneticist Luis Carvajal-Carmona a $50,000 grant to study the genetic characteristics of gastric cancer. Fri, 18 Jul 2014 00:00:00 PDT http://www.ucdmc.ucdavis.edu/publish/news/cancer/9120 Susan Mar 2014-07-18T00:00:00Z Neural stem cell discovery may aid in treatment research for deafness http://www.ucdmc.ucdavis.edu/publish/news/cancer/9106/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_9106 SACRAMENTO, Calif. (July 15, 2014) - Researchers at UC Davis School of Medicine have for the first time shown that a polysialylated glycoprotein that regulates neurodevelopment exists on the surface of cells in the adult inner ear. Tue, 15 Jul 2014 00:00:00 PDT http://www.ucdmc.ucdavis.edu/publish/news/cancer/9106 Susan Mar 2014-07-15T00:00:00Z New combination drug controls tumor growth and metastasis in mice http://www.ucdmc.ucdavis.edu/publish/news/cancer/9105/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_9105 SACRAMENTO, Calif. (July 14, 2014) - Researchers at UC Davis, University of Massachusetts and Harvard Medical School have created a combination drug that controls both tumor growth and metastasis. By combining a COX-2 inhibitor, similar to Celebrex, and an epoxide hydrolase (sEH) inhibitor, the drug controls angiogenesis (blood vessel formation), limiting a tumor’s ability to grow and spread. The study appears today in the journal Proceedings of the National Academy of Sciences. Mon, 14 Jul 2014 00:00:00 PDT http://www.ucdmc.ucdavis.edu/publish/news/cancer/9105 Dorsey Griffith 2014-07-14T00:00:00Z Pancreatic surgery complications impact hospital costs more than length of stay http://www.ucdmc.ucdavis.edu/publish/news/cancer/8695/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_8695 SACRAMENTO, Calif. (July 10, 2014) - When it comes to a specific type of pancreatic surgery, post-operative complications have a far greater impact on total cost than does how long the patient stays in the hospital, according to a published paper by UC Davis researchers. Thu, 10 Jul 2014 00:00:00 PDT http://www.ucdmc.ucdavis.edu/publish/news/cancer/8695 Dorsey Griffith 2014-07-10T00:00:00Z Surgical biopsy proves safe for selected late-stage lung cancer patients http://www.ucdmc.ucdavis.edu/publish/news/cancer/9062/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_9062 SACRAMENTO, Calif. (June 26, 2014) - Researchers at UC Davis have determined that surgical biopsies can be safely performed on select patients with late-stage non-small cell lung cancer, which should enhance their access to drugs that target specific genetic mutations such as epidermal growth factor receptor (EGFR). Thu, 26 Jun 2014 00:00:00 PDT http://www.ucdmc.ucdavis.edu/publish/news/cancer/9062 Dorsey Griffith 2014-06-26T00:00:00Z Cancer Center's specialty pharmacy program helps patients adhere to oral chemotherapy http://www.ucdmc.ucdavis.edu/publish/news/cancer/9063/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_9063 SACRAMENTO, Calif. (June 24, 2014) - A UC Davis program designed to better manage cancer patients taking oral chemotherapy drugs has demonstrated that one-on-one counseling, education and monitoring can improve adherence to potentially life-saving cancer treatments. Tue, 24 Jun 2014 00:00:00 PDT http://www.ucdmc.ucdavis.edu/publish/news/cancer/9063 Dorsey Griffith 2014-06-24T00:00:00Z Groundbreaking lung cancer trial launched http://www.ucdmc.ucdavis.edu/publish/news/cancer/9043/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_9043 SACRAMENTO, Calif. (June 16, 2014) - UC Davis Comprehensive Cancer Center patients will soon be part of an unprecedented clinical trial designed to improve access to promising therapies and speed development of effective treatments for an advanced form of lung cancer, the leading cancer killer of both men and women. Mon, 16 Jun 2014 00:00:00 PDT http://www.ucdmc.ucdavis.edu/publish/news/cancer/9043 Susan Mar 2014-06-16T00:00:00Z UC Davis faculty share cancer research innovation with partners in Madrid http://www.ucdmc.ucdavis.edu/publish/news/cancer/9033/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_9033 SACRAMENTO, Calif. (June 11, 2014) - UC Davis Comprehensive Cancer Center researchers take center stage this week in Madrid during the second in a series of workshops designed to enhance cultural, academic, scientific and business relations between UC Davis and Madrid. Wed, 11 Jun 2014 00:00:00 PDT http://www.ucdmc.ucdavis.edu/publish/news/cancer/9033 Susan Mar 2014-06-11T00:00:00Z UC Davis professor selected to work with international team on cancer http://www.ucdmc.ucdavis.edu/publish/news/cancer/8990/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_8990 SACRAMENTO, Calif. (May 29, 2014) - Paramita Ghosh, a UC Davis associate professor and expert in signal transduction pathways in prostate cancer, has been selected as one of 350 scientists to work on a project that aims to reduce public exposure to environmental agents that can lead to cancer and that hopes to inspire research into multi-faceted approaches to cancer prevention, treatment and prolonged survival. Thu, 29 May 2014 00:00:00 PDT http://www.ucdmc.ucdavis.edu/publish/news/cancer/8990 Susan Mar 2014-05-29T00:00:00Z Tailored intervention has low impact on colorectal cancer screening http://www.ucdmc.ucdavis.edu/publish/news/cancer/8940/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_8940 SACRAMENTO, Calif. (May 12, 2014) - Colorectal cancer screening saves lives, but too few people get tested. In an effort to increase these numbers,researchers from UC Davis and elsewhere investigated whether an individualized interactive multimedia computer program (IMCP) would spur patients to get screened. Mon, 12 May 2014 00:00:00 PDT http://www.ucdmc.ucdavis.edu/publish/news/cancer/8940 Dorsey Griffith 2014-05-12T00:00:00Z